CN108967800A - 一种功能性固体饮料及其制备方法 - Google Patents
一种功能性固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN108967800A CN108967800A CN201810913958.8A CN201810913958A CN108967800A CN 108967800 A CN108967800 A CN 108967800A CN 201810913958 A CN201810913958 A CN 201810913958A CN 108967800 A CN108967800 A CN 108967800A
- Authority
- CN
- China
- Prior art keywords
- parts
- peptide
- vitamin
- sea
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 21
- 239000007787 solid Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 91
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 29
- 108010035532 Collagen Proteins 0.000 claims abstract description 26
- 102000008186 Collagen Human genes 0.000 claims abstract description 26
- 229920001436 collagen Polymers 0.000 claims abstract description 26
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 22
- 241001046595 Mora moro Species 0.000 claims abstract description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 18
- 240000008042 Zea mays Species 0.000 claims abstract description 18
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 18
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 18
- 235000005822 corn Nutrition 0.000 claims abstract description 18
- 108010074686 Selenoproteins Proteins 0.000 claims abstract description 17
- 102000008114 Selenoproteins Human genes 0.000 claims abstract description 17
- 244000068988 Glycine max Species 0.000 claims abstract description 16
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 16
- 239000005018 casein Substances 0.000 claims abstract description 16
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000021240 caseins Nutrition 0.000 claims abstract description 16
- 235000013305 food Nutrition 0.000 claims abstract description 16
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 16
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 15
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 15
- 241000251511 Holothuroidea Species 0.000 claims abstract description 15
- 244000302512 Momordica charantia Species 0.000 claims abstract description 15
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 15
- 108010001441 Phosphopeptides Proteins 0.000 claims abstract description 15
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 15
- 235000012680 lutein Nutrition 0.000 claims abstract description 15
- 229960005375 lutein Drugs 0.000 claims abstract description 15
- 239000001656 lutein Substances 0.000 claims abstract description 15
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 15
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 15
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 15
- 235000003325 Ilex Nutrition 0.000 claims abstract description 14
- 241000209035 Ilex Species 0.000 claims abstract description 14
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 14
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 14
- 229920002494 Zein Polymers 0.000 claims abstract description 14
- 210000003101 oviduct Anatomy 0.000 claims abstract description 14
- 239000005019 zein Substances 0.000 claims abstract description 14
- 229940093612 zein Drugs 0.000 claims abstract description 14
- 229960001231 choline Drugs 0.000 claims abstract description 13
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 12
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 12
- 239000011718 vitamin C Substances 0.000 claims abstract description 12
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 11
- 229960003495 thiamine Drugs 0.000 claims abstract description 11
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 11
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 11
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims description 12
- 229940088594 vitamin Drugs 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 19
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 235000015097 nutrients Nutrition 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 230000035622 drinking Effects 0.000 abstract description 5
- 230000001151 other effect Effects 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 201000011510 cancer Diseases 0.000 abstract description 4
- 210000002216 heart Anatomy 0.000 abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 239000008103 glucose Substances 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 230000001473 noxious effect Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 abstract description 3
- 210000002784 stomach Anatomy 0.000 abstract description 3
- 235000001014 amino acid Nutrition 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 239000011669 selenium Substances 0.000 description 9
- 229910052711 selenium Inorganic materials 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000004224 protection Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 4
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000002929 anti-fatigue Effects 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 4
- 235000020510 functional beverage Nutrition 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 229960002591 hydroxyproline Drugs 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Chemical compound [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 4
- 229960002718 selenomethionine Drugs 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000014103 egg white Nutrition 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000003254 radicals Chemical group 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- MUSGYEMSJUFFHT-UWABRSFTSA-N 2-[(4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-34-[[(2S,3S)-2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]-methylcarbamoyl]-25-(3-amino-3-oxopropyl)-7-(3-carbamimidamidopropyl)-10-(1H-imidazol-5-ylmethyl)-19-(1H-indol-3-ylmethyl)-13,17-dimethyl-28-[(1-methylindol-3-yl)methyl]-6,9,12,15,18,21,24,27,30,33-decaoxo-31-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decazacyclopentatriacont-22-yl]acetic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cn(C)c3ccccc23)NC(=O)[C@@H](NC1=O)C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)C(N)=O MUSGYEMSJUFFHT-UWABRSFTSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108010053481 Antifreeze Proteins Proteins 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241001065361 Gynostemma Species 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000015728 Mucins Human genes 0.000 description 1
- 108010063954 Mucins Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical compound C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 235000000365 Oenanthe javanica Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- 241000191896 Rana sylvatica Species 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 235000013559 Schnittsellerie Nutrition 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 1
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 210000002932 cholinergic neuron Anatomy 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 229930186669 gynosaponin Natural products 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 208000038015 macular disease Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000037819 metastatic cancer Diseases 0.000 description 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 125000004151 quinonyl group Chemical group 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 239000012783 reinforcing fiber Substances 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种固体饮料,具体是指一种功能性固体饮料,包括下述重量份的组份:深海鳕鱼肽14~16份、大豆肽14~16份、胶原三肽14~16份、苦瓜肽14~16份、牦牛骨肽14~16份、林蛙油9~12份、海参肽0.2~0.8份、辅酶Q10 0.2~0.8份、硒蛋白0.2~0.3份、叶黄素0.05‑0.1份、酪蛋白磷酸肽0.2~0.3份、维生素B1 0.03~0.1份、胆碱0.03~0.1份、维生素C 0.05~0.15份、绞股蓝4~6份、玉米肽4~6份、玉米蛋白0.5~2份、马黛茶粉0.5~2份、食用酵母0.02~0.06份。本发明还公开了一种功能性固体饮料的制备方法。本发明的配方合理,具有缓解疲劳、增强体力、保持精力等功效,长期饮用对人体心脏、骨骼、皮肤、肠胃、肝脏等有全面性的身体调节作用,具有调节血糖血压血脂平衡、促进营养物质吸收和肠内有毒物质排除、提高免疫力、防癌抗癌等有益效果。
Description
技术领域
本发明涉及固体饮料,特别涉及一种功能性固体饮料及其制备方法。
背景技术
功能饮料是指通过调整饮料中天然营养素的成分和含量比例,以适应某些特殊人群营养需要的饮品,不以治疗疾病为目的,具有调节机体功能作用。功能饮料主要作用为抗疲劳和补充能量。目前功能饮料在我国的受到越来越多的消费者喜爱,我国逐渐成为功能性饮料的消费大国。
目前较为常见的功能性饮料大多为可直接饮用的液体功能性饮料,液体功能性饮料包装精美、饮用方便,但是液体的占用空间与重量相对固体较大,且成品的液体功能性饮料长时间存放会变成恒温,无法即时的根据需要进行温度的调整,相比而言,固体功能性饮料不仅携带方便,还能根据需要选择引用时的水温,有着很大的发展前景。
胶原蛋白是一种高分子功能性蛋白质,是皮肤的主要组成部分,富含多种氨基酸。鱼胶原蛋白肽是修复型胶原蛋白,是一种生物性高分子物质细胞外基质中最重要的组成部分,鱼胶原蛋白富含人体需要的甘氨酸、脯氨酸、羟脯氨酸等氨基酸。深海鳕鱼在安全性方面没有动物疫病和人工养殖药物残留等风险,并且含有特有的抗冻蛋白,目前是备受人们认可的鱼类胶原蛋白。将从深海鳕鱼雨披上提取的深海鳕鱼肽应用于功能性饮料,辅以其他功能性营养物质,能够大大提升功能性饮料的作用。
发明内容
针对现有技术中的上述不足,本发明提供了一种功能性固体饮料,其配方合理、对人体益处多。
为了达到上述发明目的,本发明采用的技术方案为:
一种功能性固体饮料,包括下述重量份的组份:深海鳕鱼肽14~16份、大豆肽14~16份、胶原三肽14~16份、苦瓜肽14~16份、牦牛骨肽14~16份、林蛙油9~12份、海参肽0.2~0.8份、辅酶Q10 0.2~0.8份、硒蛋白0.2~0.3份、叶黄素0.05-0.1份、酪蛋白磷酸肽0.2~0.3份、维生素B1 0.03~0.1份、胆碱0.03~0.1份、维生素C 0.05~0.15份、绞股蓝4~6份、玉米肽4~6份、玉米蛋白0.5~2份、马黛茶粉0.5~2份、食用酵母0.02~0.06份。
进一步,所述的一种功能性固体饮料,包括下述重量份的组份:深海鳕鱼肽15份、大豆肽15份、胶原三肽15份、苦瓜肽15份、牦牛骨肽15份、林蛙油10份、海参肽0.5份、辅酶Q10 0.5份、硒蛋白0.25份、叶黄素0.05份、酪蛋白磷酸肽0.25份、维生素B1 0.05份、胆碱0.05份、维生素C 0.1份、绞股蓝5份、玉米肽5份、玉米蛋白1份、马黛茶粉1份、食用酵母0.05份。
一种功能性固体饮料的制备方法,包括如下步骤:
(1)按照上述重量配比称重;
(2)将深海鳕鱼肽、大豆肽、胶原三肽、苦瓜肽、牦牛骨肽、林蛙油、海参肽、绞股蓝、玉米肽、马黛茶粉混合在一起,搅拌均匀形成原料粉:
(3)在原料粉中加入辅料辅酶Q10、硒蛋白、叶黄素、酪蛋白磷酸肽、维生素B1、胆碱、,维生素c、食用酵母及玉米蛋白,混合均匀,制剂后烘干。
本发明的配方合理,充分发挥了各原料的优势,具有缓解疲劳、增强体力、保持精力等功效,长期饮用对人体心脏、骨骼、皮肤、肠胃、肝脏等具有全面性的身体调节作用,具有调节血糖血压血脂平衡、保护细胞、保护内脏、促进营养物质吸收和肠内有毒物质排除、提高免疫力、防癌抗癌等有益效果。
具体实施方式
为了使本发明的内容更容易被清楚地理解,下面将对本发明实施例中的技术方案进行清楚、完整地描述。
深海鳕鱼肽:目前世界上鱼皮提取的胶原蛋白以深海鳕鱼皮居多,因为深海鳕鱼在安全性方面没有动物疫病和人工养殖药物残留等风险,并且含有其特有的抗冻蛋白,所以目前是备受人们认可的鱼类胶原蛋白。鱼类胶原蛋白小分子肽中富含除色氨酸和半胱氨酸外的18种氨基酸,其中维持人体生长所必需的氨基酸有7种。胶原蛋白中的甘氨酸占30份,脯氨酸和羟脯氨酸占约25份,是各种蛋白质中含量最高的;丙氨酸、谷氨酸的含量也比较高,同时还含有在一般蛋白质中少见的羟脯氨酸、焦谷氨酸和在其他蛋白质几乎不存在的羟基赖氨酸,营养十分丰富。
大豆肽:是将大分子的大豆蛋白质,再利用生物技术酶成由2到10个氨基酸组成的小分子片段,大豆肽富含22种氨基酸,其中包含9种人体不能合成的必需氨基酸。大豆肽为小分子的蛋白质,非常容易被人体吸收,适合蛋白质消化吸收不佳的人群食用,如中老年人、手术后恢复期病人、肿瘤及放化疗病人、胃肠功能不佳者等。此外,大豆肽还具有提高免疫力、增强体力、缓解疲劳、降三高等功效。
胶原三肽:是利用先进的生物工程技术由猪皮、鱼皮为原料制备的胶原蛋白的最小结构单位,是一种含有甘氨酸、脯氨酸(或羟脯氨酸)外加一个其他氨基酸的三肽,即利用先进的生物工程技术截取大的胶原蛋白分子中的对皮肤有用的小分子结构。由于胶原三肽的分子量很小,因而能够被人体充分吸收,与此同时,胶原三肽还能够极有效的渗入角质层,真皮层和头发根部细胞内。
苦瓜肽:苦瓜多肽是从苦瓜中提取出来的一种生物活性物质,由17种166个氨基酸组成,与胰岛素有相似的结构和理化指标,具有显著的调节血糖效果,是一种天然保健品。
牦牛骨:牦牛骨髓是从动物牦牛棒骨采髓,味辛、性温,归肝、肾经;功能温补祛寒,强筋健骨,用于风寒湿痹、筋骨疼痛、腰膝软弱滋肺补肾及填精益髓等;主治肾精不足、虚劳赢瘦、骨痿无力等。现代分析表明牦牛骨含有钙、铜、锌等多种元素和骨胶肽、多糖等,其促进骨骼发育和骨伤愈合的成分含量比一般食草动物骨骼高。
林蛙油:林蛙是食、药两用的珍贵蛙种,营养价值较高,是延缓衰老、滋补强壮、增强机体免疫力的最佳进补良药。林蛙油自古以来被认为是滋补强壮剂,可补虚强精壮阳,养肺滋肾益肝。可治疗肾亏劳损、神经衰弱、心慌失眠、溢汗不止、身体虚弱等一切消耗性疾病,并且对女性的身体有良好的的调节功能。
海参肽:海参的营养价值极高,富含聚氨基葡萄糖、粘多糖、海洋生物活性钙、高蛋白、黏蛋白、多肽、胶原蛋白、核酸、海参皂甙、硫酸软骨素、多种维生素、及各种氨基酸和碳水化合物等50多种养分,能有效修复受损关节软骨,恢复骨关节的正常功能;同时海参中营养成分还具有扩张血管,增加血液流量;抑制血小板聚集,增强纤维蛋白的溶解,改善微循环;促进炎症渗出物吸收;并有镇痛、镇静、抗炎、抗感染、提高机体免疫力的作用。蛋氨酸、牛磺酸,微量元素钒、硒、锗、维生素PP等,这些物质都是人体生长发育不可缺少的物质,在机体内起到不可替代的生理功能,如蛋氨酸、牛磺酸,能够促进生长发育,缓解疲劳;微量元素钒,能够使机体内铁元素更有效的吸收,改善各种贫血;元素硒、锗等则具有清除人体自由基,防癌、抗癌的作用。
辅酶Q10:辅酶Q10不仅能给心脏提供动力,还具有卓越的抗氧化,清除自由基功能,能预防血管壁脂质过氧化,预防动脉粥样硬化,并且无任何毒副作用。具体作用可体现在以下四个方面:①帮助保护心脏 辅酶Q10有助于为心肌提供充足氧气,预防突发性心脏病,尤其在心肌缺氧过程中辅酶Q10发挥关键性改善作用。②保护皮肤 长期使用辅酶Q10能够有效防止皮肤衰老,减少脸部皱纹。③抗疲劳 辅酶Q10使细胞保持良好健康的状态,因而机体充满活力,精力旺盛,脑力充沛。辅酶Q10的生物活性主要来自于其醌环的氧化还原特性和其侧链的理化性质。它是细胞自身产生的天然抗氧化剂和细胞代谢启动剂,具有保护和恢复生物膜结构的完整性、稳定膜电位作用,是机体的非特异性免疫增强剂,因此显示出极好抗疲劳作用。④防癌抗癌 研究表明,辅酶Q10有抗肿瘤作用,临床对于晚期转移性癌症有一定疗效。
硒蛋白:硒蛋白主要分为含有硒半胱氨酸的硒蛋白与含有硒甲硫氨酸的硒蛋白两种。绝大多数情况下,硒半胱氨酸是承载硒元素最主要的方式,硒半胱氨酸也因其重要性被称作第21个氨基酸,在哺乳动物体内参与蛋白组成,所以这种情况下硒蛋白也就是含有硒半胱氨酸的蛋白。例如,哺乳动物体系的硫氧还蛋白还原酶就是属于硒蛋白,硒半胱氨酸是借助掺硒辅助元件,通过UGA中止密码子介导的、特异性的编码合成。硒以硒甲硫氨酸或硒蛋氨酸为主要结合态存在于粮食中,虽然硒甲硫氨酸参入蛋白质合成可能是随机过程,但是含有硒甲硫氨酸的蛋白也称为硒蛋白。
叶黄素:是一种优良的抗氧化剂,能抵御游离基在人体内造成细胞与器官损伤,从而可防止机体衰老引发的心血管硬化、冠心病和肿瘤病等。叶黄素和玉米黄质是眼睛中仅有的2种类胡萝卜素,预防老年性眼球视网膜黄斑区病变引起的视力下降与失明是叶黄素的独特功能。
酪蛋白磷酸肽:酪蛋白磷酸肽是以牛乳酪蛋白为原料,通过生物技术制得的具有生物活性的多肽,可用于各种营养、保健食品中,能有效促进人体对钙、铁、锌等二价矿物营养素的吸收和利用,还具有固齿、健齿、修复龈齿的作用。酪蛋白磷酸肽与VD相比吸收率高,无毒副作用,更能提高其它锌、铁等二价矿物质的吸收率,酪蛋白磷酸肽还可促进小肠下部不可饱和钙的被动扩散吸收,这种吸收不受年龄和VD的变化。
维生素B1:在人体中,维生素B1广泛分布于骨骼肌、心肌、肝脏、肾脏和脑组织中,半衰期为9~10天,在植物中,维生素B1主要存在于种子的外皮和胚芽中,如米糠和麸皮中含量很丰富,在酵母菌中含量也极丰富。瘦肉、白菜和芹菜中含量也较丰富。所用的维生素B1都是化学合成的产品。在体内,维生素B1以辅酶形式参与糖的分解代谢,有保护神经系统的作用;还能促进肠胃蠕动,增加食欲。维生素B1缺乏时,可引起多种神经炎症,如脚气病、多发性神经炎等。
维生素C:维生素C又称抗坏血酸,是一种无色无臭的片状晶体,维生素C为抗体及胶原形成,组织修补,苯丙氨酸、酪氨酸、叶酸的代谢,铁、碳水化合物的利用,脂肪、蛋白质的合成,维持免疫功能,羟化与羟色胺,保持血管的完整,促进非血红素铁吸收等所必需,同时维生素C还具备有抗氧化,抗自由基,抑制酪氨酸酶的形成,从而达到美白,淡斑的功效。
胆碱:是所有生物膜的组成成分和胆碱能神经元中的乙酰胆碱的前体,机体内胆碱的获取或者通过肝,卵之类的食物或者由内源性合成的PC而来。机体除了从作为大分子PC的一部分而取得胆碱以外,不能通过其他途径生成胆碱。胆碱具有促进脑发育和提高记忆能力、保证信息传递、调控细胞凋亡、构成生物膜的重要组成成分、促进脂肪代谢、促进体内转甲基代谢、降低血清胆固醇等功能。
绞股蓝:绞股蓝主要有效成份是绞股蓝皂甙、绞股蓝糖甙(多糖)、水溶性氨基酸、黄酮类、多种维生素、微量元素、矿物质等。药材基源为葫芦科植物绞股蓝的全草,性寒,味苦,具有消炎解毒,止咳祛痰等功效,主治体虚乏力、虚劳失精、白细胞减少症、高脂血症、病毒性肝炎、慢性胃肠炎、慢性气管炎等,现多用作滋补强壮药。
玉米肽:玉米肽是从玉米中提取的蛋白质,经过定向酶切及特定小肽分离技术获得的小分子多肽物质,是一种天然食品蛋白,安全可靠,无毒副作用。玉米肽的营养丰富,含有人体必须的各种氨基酸,提供氨基酸及肽能营养。玉米肽具有降低血压、醒酒及抗疲劳、保肝、提高机体免疫力等功能,易被人体吸收。
玉米蛋白:蛋白质营养成分丰富,并具有特殊的味道和色泽,以玉米蛋白粉为原料,从中提取玉米黄素和玉米朊,开发成功能性食品,附加值大大提高。
马黛茶粉:内含多种人体必需的维生素与丰富的矿物质,包括维他命、铁、钙、纤维等,可以补充人体易缺乏的营养素,帮助排便,是具有纤体效果的纯天然饮品。马黛茶具有提神安神、清肠解腻、轻体养肤、降脂降压等作用。
食用酵母:酵母是一种肉眼看不见的微小单细胞微生物,是一种天然发酵剂。由于它含有丰富的蛋白质、维生素和酶等生理活性物质,医药上将其制成酵母片如食母生片,用于治疗因不合理的饮食引起的消化不良症。体质衰弱的人服用后能起到一定程度的调整新陈代谢机能的作用。在酵母培养过程中,如添加一些特殊的元素制成含硒、铬等微量元素的酵母,对一些疾病具有一定的疗效。如含硒酵母用于治疗克山病和大骨节病,并有一定防止细胞衰老的作用;含铬酵母可用于治疗糖尿病等。
一种功能性固体饮料,包括下述重量份的组份:深海鳕鱼肽14~16份、大豆肽14~16份、胶原三肽14~16份、苦瓜肽14~16份、牦牛骨肽14~16份、林蛙油9~12份、海参肽0.2~0.8份、辅酶Q10 0.2~0.8份、硒蛋白0.2~0.3份、叶黄素0.05-0.1份、酪蛋白磷酸肽0.2~0.3份、维生素B1 0.03~0.1份、胆碱0.03~0.1份、维生素C 0.05~0.15份、绞股蓝4~6份、玉米肽4~6份、玉米蛋白0.5~2份、马黛茶粉0.5~2份、食用酵母0.02~0.06份。
饮用本发明时需用60℃温开水冲开彻底溶解后再饮用。
实施例一:
一种功能性固体饮料,包括下述重量份的组份:深海鳕鱼肽15份、大豆肽15份、胶原三肽15份、苦瓜肽15份、牦牛骨肽15份、林蛙油10份、海参肽0.5份、辅酶Q10 0.5份、硒蛋白0.25份、叶黄素0.05份、酪蛋白磷酸肽0.25份、维生素B1 0.05份、胆碱0.05份、维生素C0.1份、绞股蓝5份、玉米肽5份、玉米蛋白1份、马黛茶粉1份、食用酵母0.05份。
一种功能性固体饮料的制备方法,包括如下步骤:
(1)按照上述重量配比称重;
(2)将深海鳕鱼肽、大豆肽、胶原三肽、苦瓜肽、牦牛骨肽、林蛙油、海参肽、绞股蓝、玉米肽、马黛茶粉混合在一起,搅拌均匀形成原料粉;
(3)在原料粉中加入辅料辅酶Q10、硒蛋白、叶黄素、酪蛋白磷酸肽、维生素B1、胆碱、,维生素c、食用酵母及玉米蛋白,混合均匀,制剂后烘干。
实施例二:
一种功能性固体饮料,包括下述重量份的组份:深海鳕鱼肽15份、大豆肽15份、胶原三肽15份、苦瓜肽15份、牦牛骨肽15份、林蛙油10份、海参肽0.5份、辅酶Q10 0.5份、硒蛋白0.25份、叶黄素0.05份、酪蛋白磷酸肽0.2份、维生素B1 0.05份、胆碱0.05份、维生素C0.15份、绞股蓝5份、玉米肽5份、玉米蛋白1份、马黛茶粉1份、食用酵母0.05份。
一种功能性固体饮料的制备方法,包括如下步骤:
(1)按照上述重量配比称重;
(2)将深海鳕鱼肽、大豆肽、胶原三肽、苦瓜肽、牦牛骨肽、林蛙油、海参肽、绞股蓝、玉米肽、马黛茶粉混合在一起,搅拌均匀形成原料粉;
(3)在原料粉中加入辅料辅酶Q10、硒蛋白、叶黄素、酪蛋白磷酸肽、维生素B1、胆碱、,维生素c、食用酵母及玉米蛋白,混合均匀,制剂后烘干。
本发明的配方合理,充分发挥了各原料的优势,具有缓解疲劳、增强体力、保持精力等功效,长期饮用对人体心脏、骨骼、皮肤、肠胃、肝脏等具有全面性的身体调节作用,具有调节血糖血压血脂平衡、保护细胞、保护内脏、促进营养物质吸收和肠内有毒物质排除、提高免疫力、防癌抗癌等有益效果。
以上所述仅为本发明专利的较佳实施例而已,并不用以限制本发明专利,凡在本发明专利的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明专利的保护范围之内。
Claims (3)
1.一种功能性固体饮料,其特征在于,包括下述重量份的组份:深海鳕鱼肽14~16份、大豆肽14~16份、胶原三肽14~16份、苦瓜肽14~16份、牦牛骨肽14~16份、林蛙油9~12份、海参肽0.2~0.8份、辅酶Q10 0.2~0.8份、硒蛋白0.2~0.3份、叶黄素0.05-0.1份、酪蛋白磷酸肽0.2~0.3份、维生素B1 0.03~0.1份、胆碱0.03~0.1份、维生素C 0.05~0.15份、绞股蓝4~6份、玉米肽4~6份、玉米蛋白0.5~2份、马黛茶粉0.5~2份、食用酵母0.02~0.06份。
2.根据权利要求1所述的一种功能性固体饮料,其特征在于:包括下述重量份的组份:深海鳕鱼肽15份、大豆肽15份、胶原三肽15份、苦瓜肽15份、牦牛骨肽15份、林蛙油10份、海参肽0.5份、辅酶Q10 0.5份、硒蛋白0.25份、叶黄素0.05份、酪蛋白磷酸肽0.25份、维生素B10.05份、胆碱0.05份、维生素C 0.1份、绞股蓝5份、玉米肽5份、玉米蛋白1份、马黛茶粉1份、食用酵母0.05份。
3.一种功能性固体饮料的制备方法,其特征在于,包括如下步骤:
(1)按照上述重量配比称重;
(2)将深海鳕鱼肽、大豆肽、胶原三肽、苦瓜肽、牦牛骨肽、林蛙油、海参肽、绞股蓝、玉米肽、马黛茶粉混合在一起,搅拌均匀形成原料粉;
(3)在原料粉中加入辅料辅酶Q10、硒蛋白、叶黄素、酪蛋白磷酸肽、维生素B1、胆碱、,维生素c、食用酵母及玉米蛋白,混合均匀,制剂后烘干。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810913958.8A CN108967800A (zh) | 2018-08-13 | 2018-08-13 | 一种功能性固体饮料及其制备方法 |
CH10052018A CH714997B1 (de) | 2018-08-13 | 2018-08-17 | Festes Präparat für die Zubereitung eines funktionellen Getränks und Verfahren zu seiner Herstellung. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810913958.8A CN108967800A (zh) | 2018-08-13 | 2018-08-13 | 一种功能性固体饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108967800A true CN108967800A (zh) | 2018-12-11 |
Family
ID=64552980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810913958.8A Pending CN108967800A (zh) | 2018-08-13 | 2018-08-13 | 一种功能性固体饮料及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN108967800A (zh) |
CH (1) | CH714997B1 (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110338344A (zh) * | 2019-08-02 | 2019-10-18 | 王中华 | 一种复合营养骨肽蝴蝶花色面及其制备方法 |
CN110604295A (zh) * | 2019-10-11 | 2019-12-24 | 王中华 | 一种复合骨肽及其制备方法 |
CN112493385A (zh) * | 2020-11-27 | 2021-03-16 | 中国科学院过程工程研究所 | 一种具有美白功能的复合蛋白肽饮料 |
KR102236944B1 (ko) * | 2020-04-29 | 2021-04-06 | (주)네오크레마 | 갈락토올리고당, 또는 갈락토올리고당 및 콜라겐 트리펩타이드를 포함하는 면역기능 개선 및 피부상태 개선용 기능성 식품조성물 및 화장료 조성물 |
CN113455602A (zh) * | 2021-05-31 | 2021-10-01 | 覃宇华 | 一种植物酵素肽饮品及其制备方法 |
CN113694179A (zh) * | 2021-08-20 | 2021-11-26 | 安徽国肽生物科技有限公司 | 一种基于牦牛骨肽的三元多肽纳米颗粒的制备方法及其应用 |
CN114343187A (zh) * | 2021-12-27 | 2022-04-15 | 北京康比特体育科技股份有限公司 | 一种含胶原三肽的保健饮料及其制备方法 |
CN114747704A (zh) * | 2022-02-28 | 2022-07-15 | 澳美制药(苏州)有限公司 | 护眼美容养颜饮料及其制备方法 |
CN114887029A (zh) * | 2022-05-20 | 2022-08-12 | 广东海洋大学 | 一种药物组合物、制备方法及其应用 |
CN115736258A (zh) * | 2022-12-29 | 2023-03-07 | 大连非得生物产业有限公司 | 牦牛骨复核低聚肽粉及其制备方法 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110959688A (zh) * | 2019-12-25 | 2020-04-07 | 河南佳禾康生物食品科技有限公司 | 一种蛋白纤维奶昔粉及其制备方法 |
CN111374243A (zh) * | 2020-04-27 | 2020-07-07 | 百生康(北京)健康产业科技有限公司 | 一种复合儿童营养素饮品及其制备方法 |
CN112715957A (zh) * | 2020-12-04 | 2021-04-30 | 广州音波美健康生物科技有限公司 | 一种解酒护肝的生物小分子肽组合物及其制备方法 |
CN112956702A (zh) * | 2021-03-25 | 2021-06-15 | 江西邦泰绿色生物合成生态产业园发展有限公司 | 一种增加骨密度的复合制剂 |
CN115363203A (zh) * | 2022-08-23 | 2022-11-22 | 广东官栈营养健康科技有限公司 | 一种具有抗衰老作用的即食花胶及其制备方法 |
CN115644326A (zh) * | 2022-09-26 | 2023-01-31 | 海南华研胶原科技股份有限公司 | 一种含胶原三肽的功能饮料及其制备方法 |
CN115944088A (zh) * | 2022-12-20 | 2023-04-11 | 江西盖比欧科技有限公司 | 一种用于健身代餐的蛋白粉及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1785069A (zh) * | 2004-12-10 | 2006-06-14 | 何建强 | 一种保健饮料及其制作方法 |
CN105476030A (zh) * | 2015-12-15 | 2016-04-13 | 北京天肽生物科技有限公司 | 一种多功能复合低聚肽营养粉 |
CN106333370A (zh) * | 2016-08-19 | 2017-01-18 | 江西中天医药生物有限公司 | 一种以富硒酵母、碳酸钙为主要原料制成的补充人体硒、钙的保健食品 |
CN106359604A (zh) * | 2016-08-24 | 2017-02-01 | 北京三元食品股份有限公司 | 一种促进肠道健康的婴儿配方乳粉及其制备方法 |
CN108113007A (zh) * | 2018-01-10 | 2018-06-05 | 安徽中森生物技术有限公司 | 一种含有大豆蛋白和牦牛骨髓的组合物及其制备方法 |
CN108142952A (zh) * | 2017-12-25 | 2018-06-12 | 安徽生物肽产业研究院有限公司 | 一种改善疲劳、提高免疫作用的复合肽粉 |
CN108308488A (zh) * | 2018-04-12 | 2018-07-24 | 北京昱健健康管理有限公司 | D-源生肽固体饮料 |
-
2018
- 2018-08-13 CN CN201810913958.8A patent/CN108967800A/zh active Pending
- 2018-08-17 CH CH10052018A patent/CH714997B1/de not_active IP Right Cessation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1785069A (zh) * | 2004-12-10 | 2006-06-14 | 何建强 | 一种保健饮料及其制作方法 |
CN105476030A (zh) * | 2015-12-15 | 2016-04-13 | 北京天肽生物科技有限公司 | 一种多功能复合低聚肽营养粉 |
CN106333370A (zh) * | 2016-08-19 | 2017-01-18 | 江西中天医药生物有限公司 | 一种以富硒酵母、碳酸钙为主要原料制成的补充人体硒、钙的保健食品 |
CN106359604A (zh) * | 2016-08-24 | 2017-02-01 | 北京三元食品股份有限公司 | 一种促进肠道健康的婴儿配方乳粉及其制备方法 |
CN108142952A (zh) * | 2017-12-25 | 2018-06-12 | 安徽生物肽产业研究院有限公司 | 一种改善疲劳、提高免疫作用的复合肽粉 |
CN108113007A (zh) * | 2018-01-10 | 2018-06-05 | 安徽中森生物技术有限公司 | 一种含有大豆蛋白和牦牛骨髓的组合物及其制备方法 |
CN108308488A (zh) * | 2018-04-12 | 2018-07-24 | 北京昱健健康管理有限公司 | D-源生肽固体饮料 |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110338344A (zh) * | 2019-08-02 | 2019-10-18 | 王中华 | 一种复合营养骨肽蝴蝶花色面及其制备方法 |
CN110604295A (zh) * | 2019-10-11 | 2019-12-24 | 王中华 | 一种复合骨肽及其制备方法 |
CN113993395A (zh) * | 2020-04-29 | 2022-01-28 | 新可利玛股份有限公司 | 包含低聚半乳糖或者低聚半乳糖及胶原三肽的用于改善免疫功能及皮肤状态的功能性食品组合物及化妆品组合物 |
KR102236944B1 (ko) * | 2020-04-29 | 2021-04-06 | (주)네오크레마 | 갈락토올리고당, 또는 갈락토올리고당 및 콜라겐 트리펩타이드를 포함하는 면역기능 개선 및 피부상태 개선용 기능성 식품조성물 및 화장료 조성물 |
WO2021221221A1 (ko) * | 2020-04-29 | 2021-11-04 | (주)네오크레마 | 갈락토올리고당, 또는 갈락토올리고당 및 콜라겐 트리펩타이드를 포함하는 면역기능 개선 및 피부상태 개선용 기능성 식품조성물 및 화장료 조성물 |
CN112493385A (zh) * | 2020-11-27 | 2021-03-16 | 中国科学院过程工程研究所 | 一种具有美白功能的复合蛋白肽饮料 |
CN113455602A (zh) * | 2021-05-31 | 2021-10-01 | 覃宇华 | 一种植物酵素肽饮品及其制备方法 |
CN113694179A (zh) * | 2021-08-20 | 2021-11-26 | 安徽国肽生物科技有限公司 | 一种基于牦牛骨肽的三元多肽纳米颗粒的制备方法及其应用 |
CN113694179B (zh) * | 2021-08-20 | 2024-05-10 | 安徽国肽生物科技有限公司 | 一种基于牦牛骨肽的三元多肽纳米颗粒的制备方法及其应用 |
CN114343187A (zh) * | 2021-12-27 | 2022-04-15 | 北京康比特体育科技股份有限公司 | 一种含胶原三肽的保健饮料及其制备方法 |
CN114747704A (zh) * | 2022-02-28 | 2022-07-15 | 澳美制药(苏州)有限公司 | 护眼美容养颜饮料及其制备方法 |
CN114887029A (zh) * | 2022-05-20 | 2022-08-12 | 广东海洋大学 | 一种药物组合物、制备方法及其应用 |
CN115736258A (zh) * | 2022-12-29 | 2023-03-07 | 大连非得生物产业有限公司 | 牦牛骨复核低聚肽粉及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CH714997B1 (de) | 2019-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108967800A (zh) | 一种功能性固体饮料及其制备方法 | |
CN102077939B (zh) | 一种肥胖人士专用的海洋特膳食品 | |
CN102077936A (zh) | 一种糖尿病患者专用的海洋特膳食品 | |
CN102077937B (zh) | 一种中青年女士专用的海洋特膳食品 | |
CN1742927A (zh) | 枸杞桑椹片及其制备工艺 | |
CN112772813A (zh) | 一种提高免疫力缓解疲劳的复合肽固体饮料及其制备方法 | |
CN102526698A (zh) | 虫草多肽氨基酸营养液 | |
GB2268871A (en) | Composition for use as a food or food supplement | |
CN102077945A (zh) | 一种人流、产后专用的海洋特膳食品 | |
CN102077944B (zh) | 一种前列腺患者专用的海洋特膳食品 | |
CN102396707A (zh) | 一种养颜瘦身营养食品配方 | |
CN105250199A (zh) | 含珍珠粉的可食用面膜 | |
CN111374312A (zh) | 一种补充全面营养且易吸收的健康食品 | |
CN1101700C (zh) | 多肽口服液 | |
WO2022165700A1 (zh) | 一种多肽营养粉及其制备方法 | |
CN104757689A (zh) | 一种松黄维生素固体饮料及其制备方法 | |
CN107668569A (zh) | 一种延缓衰老的海参蜂王浆及其生产方法 | |
CN1943695A (zh) | 一种甲鱼制剂及其生产工艺 | |
KR20080090808A (ko) | 피부미용을 위한 건강보조식품의 조성물 | |
CN102077943A (zh) | 一种记忆力衰退者专用的海洋特膳食品 | |
CN114947085A (zh) | 一种含螺旋藻与藻蓝蛋白的生椰拿铁味多功能营养果冻及其制备方法 | |
CN104366349A (zh) | 脆枣松子营养粥及制作方法 | |
CN108013459A (zh) | 一种具有减肥美容功能的保健食品及其制备方法 | |
CN114521654A (zh) | 一种激活细胞能量、修复受损器官组织细胞、强化干细胞治疗潜能的食疗组方 | |
CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181211 |